Prevest Denpro Board of Directors

Get the latest insights into the leadership at Prevest Denpro. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Atul Modi Chairman & Managing Director
Mrs. Namrata Modi WholeTime Director & CFO
Dr. Sai Kalyan Surapaneni Director - R & D
Mr. Vaibhav Munjal Director
Ms. Niharika Modi Non Executive Director
Dr. Nikhil Shrikant Bobade Independent Director
Dr. Sudeep Murthy Independent Director
Mr. Pardeep Gandotra Independent Director

Prevest Denpro Share price

PREVEST

572

9.95 (-1.71%)
Last updated on 4 Sep, 2025 | 15:11 IST
BUYSELL
Today's High

581.95

Today's Low

567.55

52 Week Low

393.60

52 Week High

686.00

The current prices are delayed, login to your account for live prices

Prevest Denpro FAQs

The board at Prevest Denpro consists of experienced professionals, including Mr. Atul Modi , Mrs. Namrata Modi , and others, overseeing the company’s strategic and corporate governance.

Directors at Prevest Denpro are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Atul Modi is the current chairman at Prevest Denpro.

Executive directors at Prevest Denpro are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Prevest Denpro adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Prevest Denpro, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.